Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rank

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Protein Science : a Publication of the Protein Society|February 1, 1997
A desolvation barrier to hydrophobic cluster formation may contribute to the rate-limiting step in protein foldingJ A Rank, D Baker
Current Opinion in Allergy and Clinical Immunology|October 23, 2013
Reducing and managing systemic reactions to immunotherapyAnupama Ravi, Matthew A Rank
Biophysical Chemistry|July 2, 1998
Contributions of solvent-solvent hydrogen bonding and van der Waals interactions to the attraction between methane molecules in waterJ A Rank, D Baker
Current Opinion in Allergy and Clinical Immunology|May 21, 2021
Optimal use of intranasal corticosteroids and intranasal saline, is there a clear answer?Catherine M Freeman, Matthew A Rank
Der Internist|May 7, 2003
[21-year-old patient with myocardial infarct, transient cerebral ischemia and thrombocytopenia]A Rank, L Lindner, E Hiller
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2014
Improving the safety of immunotherapyMatthew A Rank, David I Bernstein
The Journal of Allergy and Clinical Immunology. in Practice|September 13, 2014
The risks, benefits, and uncertainties of stepping down asthma medicationsMatthew A Rank, Stephen P Peters
The Journal of Allergy and Clinical Immunology. in Practice|September 13, 2014
Multiple chronic conditions and asthma: implications for practice and researchMatthew A Rank, Nilay D Shah
Current Allergy and Asthma Reports|February 18, 2015
Assessing the risks and benefits of step-down asthma care: a case-based approachJohn B Hagan, Matthew A Rank
Annals of Internal Medicine|February 2, 2026
In severe chronic rhinosinusitis with polyps and asthma, dupilumab improved nasal polyp score and sense of smell vs. omalizumab at 24 wkDerek K Chu, Matthew A Rank,
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Protein Science : a Publication of the Protein Society|February 1, 1997
A desolvation barrier to hydrophobic cluster formation may contribute to the rate-limiting step in protein foldingJ A Rank, D Baker
Current Opinion in Allergy and Clinical Immunology|October 23, 2013
Reducing and managing systemic reactions to immunotherapyAnupama Ravi, Matthew A Rank
Biophysical Chemistry|July 2, 1998
Contributions of solvent-solvent hydrogen bonding and van der Waals interactions to the attraction between methane molecules in waterJ A Rank, D Baker
Current Opinion in Allergy and Clinical Immunology|May 21, 2021
Optimal use of intranasal corticosteroids and intranasal saline, is there a clear answer?Catherine M Freeman, Matthew A Rank
Der Internist|May 7, 2003
[21-year-old patient with myocardial infarct, transient cerebral ischemia and thrombocytopenia]A Rank, L Lindner, E Hiller
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2014
Improving the safety of immunotherapyMatthew A Rank, David I Bernstein
The Journal of Allergy and Clinical Immunology. in Practice|September 13, 2014
The risks, benefits, and uncertainties of stepping down asthma medicationsMatthew A Rank, Stephen P Peters
The Journal of Allergy and Clinical Immunology. in Practice|September 13, 2014
Multiple chronic conditions and asthma: implications for practice and researchMatthew A Rank, Nilay D Shah
Current Allergy and Asthma Reports|February 18, 2015
Assessing the risks and benefits of step-down asthma care: a case-based approachJohn B Hagan, Matthew A Rank
Annals of Internal Medicine|February 2, 2026
In severe chronic rhinosinusitis with polyps and asthma, dupilumab improved nasal polyp score and sense of smell vs. omalizumab at 24 wkDerek K Chu, Matthew A Rank,
Pageof 13